Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Italian reference price cuts invalidated, but still on the agenda

This article was originally published in Clinica

Executive Summary

Medtech suppliers in Italy can breathe a sigh of relief after government plans to enforce cuts in existing contract prices have been ruled unlawful. The ruling, passed by a regional court but with national impact, means that the much-criticized reference pricing calculation, due to have come into force in January, is on hold – at least for the time being. Price cuts are still on the agenda but Italy’s legislators now need to redefine the methodology for implementing these cuts.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT100380

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel